These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15257119)

  • 1. Predicting CAD events: C-reactive protein a marker for atherosclerotic risk.
    MacKenzie JR
    Nurse Pract; 2004 Jun; 29(6):14-5, 19-27; quiz 27-9. PubMed ID: 15257119
    [No Abstract]   [Full Text] [Related]  

  • 2. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A12 as a marker to predict cardiovascular events in patients with chronic coronary artery disease.
    Saito T; Hojo Y; Ogoyama Y; Hirose M; Ikemoto T; Katsuki T; Shimada K; Kario K
    Circ J; 2012; 76(11):2647-52. PubMed ID: 22786469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials and tribulations. Cholesterol veers off script.
    Couzin J
    Science; 2008 Oct; 322(5899):220-3. PubMed ID: 18845747
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary artery disease prognosis and C-reactive protein levels improve in proportion to percent lowering of low-density lipoprotein.
    O'Keefe JH; Cordain L; Jones PG; Abuissa H
    Am J Cardiol; 2006 Jul; 98(1):135-9. PubMed ID: 16784936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein and cardiovascular risk: more fuel to the fire.
    Boekholdt SM; Kastelein JJ
    Lancet; 2010 Jan; 375(9709):95-6. PubMed ID: 20031200
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.
    Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K
    Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is C-reactive protein a predictor of perioperative events before coronary artery bypass?
    Okamura Y
    Circ J; 2009 May; 73(5):818-9. PubMed ID: 19390157
    [No Abstract]   [Full Text] [Related]  

  • 10. C reactive protein--marker for atherothrombotic events.
    Gogna A; Sinha RS; Gupta B
    J Assoc Physicians India; 1999 Jun; 47(6):631-3. PubMed ID: 10999165
    [No Abstract]   [Full Text] [Related]  

  • 11. Atherosclerosis imaging and circulating blood biomarkers: insights into subclinical atherosclerotic plaque burden and disease activity.
    Schoenhagen P
    Int J Cardiovasc Imaging; 2005 Aug; 21(4):443-5. PubMed ID: 16047126
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD; Kip KE; Marroquin OC; Ridker PM; Kelsey SF; Shaw LJ; Pepine CJ; Sharaf B; Bairey Merz CN; Sopko G; Olson MB; Reis SE;
    Circulation; 2004 Feb; 109(6):726-32. PubMed ID: 14970107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
    Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
    Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small LDL and hsCRP as new risk factors for coronary artery disease.
    Brown CL; Garrett B; Superko HR
    J Med Assoc Ga; 2001 Dec; 90(4):11-6. PubMed ID: 11845678
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
    Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
    Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein--marker for atherothrombotic events.
    Gogna A; Sinha RS; Gupta B
    J Assoc Physicians India; 1999 Aug; 47(8):818-20. PubMed ID: 10778631
    [No Abstract]   [Full Text] [Related]  

  • 18. LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk.
    Ofori-Asenso R; Zoungas S; Tonkin A; Liew D
    Clin Pharmacol Ther; 2018 Aug; 104(2):235-238. PubMed ID: 30004113
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease.
    Nishikura T; Koba S; Yokota Y; Hirano T; Tsunoda F; Shoji M; Hamazaki Y; Suzuki H; Itoh Y; Katagiri T; Kobayashi Y
    J Atheroscler Thromb; 2014; 21(8):755-67. PubMed ID: 24717762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.
    Nasu K; Terashima M; Habara M; Ko E; Ito T; Yokota D; Ishizuka S; Kurita T; Kimura M; Kinoshita Y; Asakura Y; Tsuchikane E; Katoh O; Suzuki T
    JACC Cardiovasc Interv; 2013 Jul; 6(7):746-55. PubMed ID: 23769651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.